Skip to main content
Log in

Guidelines for radioiodinated MIBG scintigraphy in children

  • Blue Pages
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

These guidelines on the use of radioiodinated 99mTc-MIBG scintigraphy in children, which summarise the views of the Paediatric Committee of the European Association of Nuclear Medicine, provide a framework which may prove helpful to nuclear medicine teams in daily practice. They have been influenced by the conclusions of the "Consensus Guidelines for MIBG Scintigraphy" (Paris, November 6, 1997) of the European Neuroblastoma Group and by those of the Oncological Committee of the French Society of Nuclear Medicine. The guidelines should be taken in the context of "good practice" and any local/national rules which apply to nuclear medicine examinations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Giammarile F, Boneu A, Edeline V, Lumbroso J, Siles S, Wioland M. Guide de realisation de la scintigraphie à la méta-iodobenzylguanidine (mIBG) en oncologie pédiatrique. Med Nucl 2000; 24:35–41.

    Google Scholar 

  2. Shapiro B, Copp JE, Sisson JC, Eyre PL, Wallis J, Beierwaltes WH. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med 1985; 26:576–585.

    Google Scholar 

  3. Sisson JC, Shulkin BL. Nuclear medicine imaging of pheochromocytoma and neuroblastoma. Q J Nucl Med 1999; 43:217–223.

    Google Scholar 

  4. Leung A, Shapiro B, Hattner R, Kim E, de Kraker J, Ghazzar N, Hartmann O, Hoefnagel CA, Jamadar DA, Kloos R, Lizotte P, Lumbroso J, Rufini V, Shulkin BL, Sisson JC, Thein A, Troncone L. Specificity of radioiodinated MIBG for neural crest tumors in childhood. J Nucl Med 1997; 38:1352–1357.

    Google Scholar 

  5. Khafagi FA, Shapiro B, Fischer M, Sisson JC, Hutchinson R, Beierwaltes WH. Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: role of iodine131I-metaiodobenzylguanidine. Eur J Nucl Med 1991; 18:191–198.

    Google Scholar 

  6. Shulkin BL, Shapiro B. Current concepts on the diagnostic use of MIBG in children. J Nucl Med 1998; 39:679–688.

    Google Scholar 

  7. Wieland DM, Wu J, Brown LE, Mangner TJ, Swanson DP, Beierwaltes WH. Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with131I-iodobenzylguanidine. J Nucl Med 1980; 21:349–353.

    Google Scholar 

  8. Khafagi FA, Shapiro B, Gross MD. The adrenal gland. In: Maisey MN, Britton KE, Gilday DL, eds. Clinical nuclear medicine. London: Chapman & Hall; 1989:271–291.

  9. Kinnier-Wilson LM, Draper GJ. Neuroblastoma, its natural history and prognosis: a study of 487 cases. Br Med J 1974; 3:301–307.

    Google Scholar 

  10. Young JL Jr, Ries LG, Silverberg E, Horm JW, Miller RW. Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer 1986; 58 (2 Suppl):598–602.

    Google Scholar 

  11. Jacobs A, Delree M, Desprechins B, Otten J, Ferster A, Jonckheer MH, Mertens J, Ham HR, Piepsz A. Consolidating the role of131I-MIBG-scintigraphy in childhood neuroblastoma: five years of clinical experience. Pediatr Radiol 1990; 20:157–159.

    Google Scholar 

  12. Gelfand MJ. Meta-iodobenzylguanidine in children. Semin Nucl Med 1993; 23:231–242.

    Google Scholar 

  13. Lumbroso JD, Guermazi F, Hartmann O, et al. Meta-iodobenzylguanidine (mIBG) scans in neuroblastoma: sensitivity and specificity, a review of 115 scans. Prog Clin Biol Res 1988; 271:689–705.

    Google Scholar 

  14. Parisi MT, Greene MK, Dykes TM, Moraldo TV, Sandler ED, Hattner RS. Efficacy of metaiodobenzylguanidine as a scintigraphic agent for the detection of neuroblastoma. Invest Radiol 1992; 27:768–773.

    Google Scholar 

  15. Moyes J, McCready VR, Fullbrook A. Neuroblastoma: MIBG in its diagnosis and management. Berlin Heidelberg New York: Springer, 1989.

  16. Perel Y, Conway J, Kletzel M, Goldman J, Weiss S, Feyler A, Cohn SL. Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma. J Pediatr Hematol Oncol 1999; 21:13–18.

    Google Scholar 

  17. Hoefnagel CA, De Kraker J, Valdes Olmos RA, Voute PA. [131I]MIBG as a first line treatment in advanced neuroblastoma. Q J Nucl Med 1995; 39 (4 Suppl 1): 61–64.

    Google Scholar 

  18. Lumbroso J, Hartmann O, Schlumberger M. Therapeutic use of131I-metaiodobenzylguanidine in neuroblastoma: a phase II study in 26 patients. "Societe Francaise d'Oncologie Pediatrique" and Nuclear Medicine Co-investigators. J Nucl Biol Med 1991; 35:220–223.

    Google Scholar 

  19. Mairs RJ. Neuroblastoma therapy using radiolabelled [131I]meta-iodobenzylguanidine 131I-MIBG in combination with other agents. Eur J Cancer 1999; 35:1171–1173.

    Google Scholar 

  20. Gordon I, Peters AM, Gutman A, Morony S, Dicks-Mireaux C, Pritchard J. Skeletal assessment in neuroblastoma—the pitfalls of iodine-123-MIBG scans. J Nucl Med 1990; 31:129–134.

    Google Scholar 

  21. Solanki KK, Bomanji J, Moyes J, Mather SJ, Trainer PJ, Britton KE. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun 1992; 13:513–521.

    Google Scholar 

  22. Piepsz A, Hahn K, Roca I, Ciofetta G, Toth G, Gordon I, Kolinska J, Gwidlet J. A radiopharmaceuticals schedule for imaging in paediatrics. Paediatric Task Group European Association Nuclear Medicine. Eur J Nucl Med 1990; 17:127–129.

    Google Scholar 

  23. Stabin MG, Gelfand MJ. Dosimetry of pediatric nuclear medicine procedures. Q J Nucl Med 1998; 42:93–112.

    Google Scholar 

  24. Pintelon H, Jonckheer MH, Piepsz A. Paediatric nuclear medicine procedures: routine sedation or management of anxiety? Nucl Med Commun 1994; 15:664–666.

    Google Scholar 

  25. Rufini V, Fisher GA, Shulkin BL, Sisson JC, Shapiro B. Iodine-123-MIBG imaging of neuroblastoma: utility of SPECT and delayed imaging. J Nucl Med 1996; 37:1464–1468.

    Google Scholar 

  26. Rufini V, Giordano A, Di Giuda D, Petrone A, Deb G, De Sio L, Donfrancesco A, Troncone L.123I-MIBG scintigraphy in neuroblastoma: a comparison between planar and SPECT imaging. Q J Nucl Med 1995; 39 (4 Suppl 1):25–28.

    Google Scholar 

  27. Gelfand MJ, Elgazzar AH, Kriss VM, Masters PR, Golsch GJ. Iodine-123-MIBG SPECT versus planar imaging in children with neural crest tumors. J Nucl Med 1994; 35:1753–1757.

    Google Scholar 

  28. Nakajo M, Shapiro B, Copp J, Kalff V, Gross MD, Sisson JC, Beierwaltes WH. The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine I-131 MIBG) in man: evaluation by scintigraphy. J Nucl Med 1983; 24:672–682.

    Google Scholar 

  29. Bonnin F, Lumbroso J, Tenenbaum F, Hartmann O, Parmentier C. Refining interpretation of MIBG scans in children. J Nucl Med 1994; 35:803–810.

    Google Scholar 

  30. Lumbroso J, Giammarile F, Hartmann O, Bonnin F, Parmentier C. Upper clavicular and cardiac meta-123I-iodobenzylguanidine uptake in children. Q J Nucl Med 1995; 39 (4 Suppl 1):17–20.

    Google Scholar 

Download references

Acknowledgements

The authors thank Dr. C.A. Hoefnagel, Dr. J. Lumbroso and Dr. S. Meller for their valuable advice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pierre Olivier.

Additional information

Under the auspices of the Paediatric Committee of the European Association of Nuclear Medicine

Rights and permissions

Reprints and permissions

About this article

Cite this article

Olivier, P., Colarinha, P., Fettich, J. et al. Guidelines for radioiodinated MIBG scintigraphy in children. Eur J Nucl Med Mol Imaging 30, B45–B50 (2003). https://doi.org/10.1007/s00259-003-1138-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-003-1138-9

Keywords

Navigation